Peer Review of “Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years”

Peer Review of “Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years”

Bibliographic Details
Main Author:	Heikki Vapaatalo
Format:	Article
Language:	English
Published:	JMIR Publications 2023-01-01
Series:	JMIRx Med
Online Access:	https://med.jmirx.org/2023/1/e45278

Similar Items

Peer Review of “Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years”
by: Calogero Caruso
Published: (2023-01-01)

Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years
by: Valquiria Bueno, et al.
Published: (2023-01-01)

Authors’ Responses to Peer Review Reports for "Angiotensin Converting Enzyme 1 Expression in the Leukocytes of Adults Aged 64 to 67 Years"
by: Valquiria Bueno, et al.
Published: (2023-01-01)

Angiotensin converting enzyme inhibitors /
by: DeBrue, Anne N.
Published: (c200)

Angiotensin-Converting Enzyme and Heart Failure
by: Sara Álvarez-Zaballos, et al.
Published: (2023-07-01)

Prevention with angiotensin-converting enzyme (ACE) inhibitors
by: Ertl, G, et al.
Published: (1992)

[Prevention with angiotensin-converting enzyme (ACE) inhibitors]
by: Ertl, G, et al.
Published: (1992)

Angioedema secondary to angiotensin converting enzyme inhibitors
by: Thiruventhiran, T., et al.
Published: (1999)

Angiotensin-Converting Enzyme 2: The First Decade
by: Nicola E. Clarke, et al.
Published: (2012-01-01)

Expression of angiotensin converting enzyme 2 in patients with oral squamous cell carcinoma
by: Shivani Sivasakthivel, et al.
Published: (2024-06-01)

Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
by: Min Joo Choi, et al.
Published: (2022-03-01)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012-01-01)

Angiotensin‐converting enzyme 2 deficiency accelerates and angiotensin 1‐7 restores age‐related muscle weakness in mice
by: Hikari Takeshita, et al.
Published: (2018-10-01)

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
by: Baigent, C, et al.
Published: (2001)

The use of angiotensin-converting enzyme inhibitors in general medicine
by: M.L.I. Mashitisho
Published: (2012-08-01)

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion
by: Sarah Zaheer, et al.
Published: (2017-01-01)

Angiotensin Converting Enzyme Activity in Compensatory Renal Hypertrophy
by: Nermina Babić, et al.
Published: (2007-02-01)

Progress of angiotensin converting enzyme 2 in cardiovascular diseases
by: JIAO Xiao-lu, QIN Yan-wen
Published: (2020-05-01)

Angiotensin-converting enzyme 2 in dogs with Dirofilaria immitis
by: Darcy B. Adin, et al.
Published: (2023-04-01)

Re-evaluating serum angiotensin-converting enzyme in sarcoidosis
by: Shi-yue Zheng, et al.
Published: (2023-10-01)

Angiotensin-Converting Enzyme Genotype and Acute Pancreatitis in Turkey
by: Kasap E, et al.
Published: (2009-01-01)

Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
by: Sarah Alabsi, et al.
Published: (2023-02-01)

Expression of circulating angiotensin‐converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids
by: Xiang Ma, et al.
Published: (2023-07-01)

I/D POLYMORPHISM OF ANGIOTENSINE CONVERTING ENZYME IN CHD PATIENTS OF DIFFERENT AGE AND GENDER
by: T. Yu. Rebrova, et al.
Published: (2014-10-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease
by: Martin Wawruch, et al.
Published: (2023-01-01)

Ramipril Reduces Acylcarnitines and Distinctly Increases Angiotensin-Converting Enzyme 2 Expression in Lungs of Rats
by: Joanna Kosacka, et al.
Published: (2022-03-01)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021-01-01)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
by: Jin Sun Choi, et al.
Published: (2023-11-01)

Measured haplotype analysis of the angiotensin-I converting enzyme gene
by: Keavney, B, et al.
Published: (1999)

Structure, evolutionary conservation, and functions of angiotensin- and endothelin-converting enzymes.
by: Macours, N, et al.
Published: (2004)

Measured haplotype analysis of the angiotensin-I converting enzyme gene.
by: Keavney, B, et al.
Published: (1998)

Novel peptides with antioxidant and angiotensin converting enzyme inhibitory activity
by: Saari, Nazamid, et al.
Published: (2013)

Human angiotensin I-converting enzyme gene and endurance performance.
by: Myerson, S, et al.
Published: (1999)

CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL
by: D. A. Napalkov, et al.
Published: (2016-01-01)

An angiotensin-converting enzyme inhibitor in the combination treatment of rheumatoid arthritis
by: E. B. Komarova, et al.
Published: (2017-09-01)

Neutrophil hypersegmentation in children receiving angiotensin converting enzyme inhibitors
by: Vedat Okutan, et al.
Published: (2008-10-01)

Angiotensin-converting enzyme 2: virus accomplice or host defender?
by: Jiyan Wang, et al.
Published: (2023-09-01)

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
by: Neil H. Crooks, et al.
Published: (2014-01-01)